Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neurofibroma × Ranibizumab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 4 Retinal Diseases 1 Neurofibromatosis 1 1 Neurofibroma 1 Melanoma 1 Macular Edema 1 Glaucoma, Neovascular 1 Conjunctival Neoplasms 1

Interventions

tipifarnib 1 peginterferon alfa-2b 1 nilotinib 1 mirdametinib 1 binimetinib 1 Vincristine 1 Temozolomide 1 Sirolimus 1 Ranibizumab 1 Radiosurgery 1 Mn-PyC3A 1 Imatinib Mesylate 1 Everolimus 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00657202 2016-07-07

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

Massachusetts General Hospital

Phase EARLY_PHASE1 Completed

Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡